News

Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” first quarter ...
We recently published a list of 15 Recent Activist Investor Campaigns. In this article, we are going to take a look at where ...
Investors in Illumina Inc (Symbol: ILMN) saw new options become available today, for the June 6th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ILMN ...
In this article, we are going to take a look at where Illumina, Inc. (NASDAQ:ILMN) stands against other recent activist investor campaigns. Economic uncertainty and market volatility are some of ...
San Diego, CA.-based Illumina Inc. provides sequencing and array-based solutions for genetic and genomic analysis across a wide range of markets, driving their adoption in research and clinical ...
Illumina, Inc. (NASDAQ:ILMN – Get Free Report)’s stock price hit a new 52-week low during trading on Wednesday after Royal Bank of Canada lowered their price target on the stock from $128.00 ...
In this article, we are going to take a look at where Illumina, Inc. (NASDAQ:ILMN) stands against the other stocks targeted by activist hedge funds. Shareholder activism continued at a record pace ...
In the preceding three months, 14 analysts have released ratings for Illumina (NASDAQ:ILMN), presenting a wide array of perspectives from bullish to bearish. The table below provides a snapshot of ...
Investors in Illumina Inc (Symbol: ILMN) saw new options become available today, for the May 9th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ILMN ...
Investors in Illumina Inc (Symbol: ILMN) saw new options become available today, for the May 23rd expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ILMN ...
"By expanding our collaboration with Illumina, we are combining our strengths in technology and data analytics with their ...
In a report released yesterday, Eve Burstein from Bernstein maintained a Hold rating on Illumina (ILMN – Research Report), with a price target ...